Florida Cancer Drug Price Gouging
IncSmart Florida (Small Business and Startups) - Florida drug company is accused of price gouging.  Cancer drug, Gleostine, has skyrocketed nearly 1400% since it's purchase from Bristol-Myers Squib from NextSource.   This potentially life saving drug is now out of reach for patients suffering from brain tumors and Hodgins lymphoma.  Stories of Martin Shkerli come roaring back before 2018 begins.

Robert DiCrisci, is the chief executive of NextSource Biotechnology LLC.  They have increased the price of Gleostine 9 times.  12 percent in November following a 20 percent increase in August.  Gleostine is now $768 per pill.  The Trump administration is trying to lower pharmaceutical prices through the U.S. Food and Drug Administration.  They are offering to expedite the regulatory review process for more than 300 drugs like  Gleostine that lack generic competitors.
By IncSmart Staff Writers

Starting a Business in Florida - Florida Corporation - Florida LLC

For 10 years, IncSmart.biz Business Services has helped companies and people from all over the world form Florida Corporations and Florida Limited Liability Companies. When you call, email, instant message or live chat with our office, expect personal attention.  We are very excited about helping you form your new company.  Each state is so different when it comes to filing documents, you will know right away you are in the right place.


Think Smart.  Think IncSmart.

Speak with IncSmart
Phone: 888-681-9777
Mon-Fri 8am to 4pm PT

Registered Agent Services


Add Comment